Načítá se...
Treatment with rituximab in idiopathic membranous nephropathy
BACKGROUND: Rituximab represents a valid therapeutic option to induce remission in patients with primary glomerulonephritis. Despite several studies proving its efficacy in improving outcomes in patients with membranous nephropathy (MN), its role in therapeutic protocols is not yet defined. METHODS:...
Uloženo v:
| Vydáno v: | Clin Kidney J |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5162414/ https://ncbi.nlm.nih.gov/pubmed/27994855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw091 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|